Vascular surgeons at Allegheny General Hospital announced they are the first team in Western Pennsylvania, and the third in the United States, to participate in a clinical trial that studies the diagnostic capabilities of artificial intelligence to detect deep vein thrombosis in cardiac patients.

Allegheny General Hospital serves as the academic medical center of Pittsburgh-based Allegheny Health Network.

Through a partnership with ThinkSono, a UK-based AI company, vascular surgeons and researchers at AHN’s Cardiovascular Institute will use an AI-powered ultrasound technology to diagnose deep-vein thrombosis, all from point-of-care images captured by a clinician using a handheld scanner and smartphone.